Tilray | TRLY - 税前利润

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 5.07B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	税前利润	更改		日
Acasti Pharma	USD -2.88M		564K	2026-03
Akebia Therapeutics	USD -11.24M		12.39M	2025-12
Alaunos Therapeutics	USD -7.84M		633K	2023-12
Aurora Cannabis	CAD 11.41M		12.99M	2026-03
Avita Medical	AUD -11.64M		12.13M	2025-12
Canopy Growth	CAD -157.96M		95.71M	2026-03
Cronos Group	USD -12.39M		44.16M	2025-12
Dianthus Therapeutics	USD -40.83M		23.6M	2026-03
Divis Laboratories Ltd	INR 9.63B		1.09B	2026-03
Ionis Pharmaceuticals	USD -93M		135M	2026-03
IQVIA Holdings	USD 6.22B		5.68B	2026-03
Knight Therapeutics	CAD -1.92M		13.69M	2025-09
Moderna	USD -799M		612M	2025-12
Organigram Holdings	CAD -921K		40.8M	2026-03
Organon & Co	USD 213M		361M	2026-03
Revvity	USD 91.56M		35.88M	2025-12
Tectonic Therapeutic	USD -18.97M		63K	2025-12
Tilray	USD -39.96M		39.19M	2025-09
Viatris	USD -343M		335.1M	2025-12
Xeris Pharmaceuticals	USD 2.23M		8.85M	2026-03
Zealand Pharma A/S	-406.5M		39.77M	2025-12